Atlantic Provinces Pediatric Hematology Oncology Network Réseau d oncologie et d hématologie pédiatrique des provinces de l Atlantique
|
|
- Georgina Bradford
- 6 years ago
- Views:
Transcription
1 Atlantic Provinces Pediatric Hematology Oncology Network Réseau d oncologie et d hématologie pédiatrique des provinces de l Atlantique Reviewed and approved by specialists at the IWK Health Centre, Halifax, NS and the Janeway Children s Health and Rehabilitation Centre, St. John s, NL. 5850/5980University Avenue, PO Box 9700, Halifax, NS, B3K 6R8 APPHON/ROHPPA supportive care guidelines are developed by Atlantic Provinces health professional specialists using evidence-based or best practice references. Format and content of the guidelines will change as they are reviewed and revised on a periodic basis. Care has been taken to ensure accuracy of the information. However, any physician or health professional using these guidelines will be responsible for verifying doses and administering medications and care according to their own institutional formularies and policies and acceptable standards of care. Unofficial document if printed. To ensure that this printed is the latest version, please check website Guidelines for Varicella Zoster/Herpes Zoster Varicella zoster is a highly contagious, DNA virus which is considered relatively benign in normal children but can cause disseminated and potentially fatal disease in immunocompromised children. The illness is spread primarily by respiratory secretions and direct contact. The disease can be more severe in adolescents and adults. It is possible, although uncommon, to get chicken pox more than once, especially if the first episode was before two years of age. Risk: Who is at risk? Children at high risk for severe or disseminated chickenpox or shingles are those in any of the following patient groups: receiving chemotherapy or radiotherapy known immunodeficiency, or immunosuppressed state (i.e., post solid organ transplant) receiving high doses of systemic corticosteroids ( 2 mg/kg per day of prednisone or its equivalent or 20 mg/day of prednisone or its equivalent if weight >10 kg) completed chemotherapy in last six months, without a previous history of chicken pox illness bone marrow transplantation up to one (1) year post transplant or longer if still on immunosuppression - Bone marrow transplant patients should still be considered at risk, even with normal levels of IgG, until one year post transplant or off all immunosuppression with good T cell function. Guidelines for Varicella Zoster/Herpes Zoster January 2005 Page 1 of 6
2 Who is not at risk? Children who have previously received the varicella vaccine or had a previous history of chickenpox, and have a documented immune varicella titre, are not at risk for severe chickenpox. Diagnosis: Clinical picture is usually diagnostic. vesicular rash (raised red spots filled with clear fluid) often associated with elevated temperature and pruritus can occur anywhere on the body including in the mouth, scalp is often the first area involved herpes zoster ( shingles or zoster ) appears as grouped vesicular lesions in the distribution of 1 to 3 dermatomes, sometimes accompanied by localized pain or parasthesias Labs: culture in viral media (aggressively swab BASE OF LESION) vesicular scrapings: DFA (Direct Fluorescent Antibody test) - distinguishes VZV from HSV (more rapid than culture) PCR (Polymerase Chain Reaction) on CSF for suspected VZV encephalitis; can distinguish wild type strains from vaccine virus (very sensitive). Requires consult with Infectious Disease Incubation period: usually days (10-21 days) if child received zoster immune globulin (VZIG), incubation period may be as long as 28 days isolate child in contact with varicella from other immune compromised children during the incubation period Chemotherapy - The decision to hold chemotherapy during the incubation period is based on the intensity of exposure, the general condition of the patient, and the intensity, phase and type of the chemotherapy. High risk patients may be asked to temporarily hold chemotherapy during incubation period (e.g., delay in planned Bone Marrow Transplant). Chemotherapy and other therapy during the incubation period must be discussed with the pediatric hematologist/oncologist. Contact: Varicella is highly contagious and transmitted by air or droplet and direct contact with lesions. It is infectious for hours prior to onset of rash and until the last vesicle is scabbed over. The most contagious phase is during the development of the vesicles. Significant contact: 5 minutes of face to face contact or an hour in a room with an individual in the infectious phase of varicella presence in the same household within 48 hours of a person developing chickenpox Guidelines for Varicella Zoster/Herpes Zoster January 2005 Page 2 of 6
3 simultaneous play with the same objects as a person with shingles on any part of the body presence in the room for more than one hour with a person with shingles on an exposed area of skin or direct contact with a lesion Guidelines for Varicella Zoster/Herpes Zoster January 2005 Page 3 of 6
4 Prevention of Chicken Pox: Avoiding contact Avoid visiting anyone with known chicken pox. Avoid contact with anyone who has had contact with an individual with chicken pox during the isolation period (8-21 days, and 8-28 days for those who received VZIG). Isolation period differs from incubation period in that an individual can be contagious for 2 days prior to the onset of rash. Avoid school if an outbreak of chickenpox occurs within the school. Notify school to increase school awareness of chickenpox illness in classmates of the child. Notify caregivers and friends of the risk to these children and the necessity of informing the family and the appropriate health care professional of contacts. Siblings should be immune by previous disease or vaccine. If they are not immune, they should be vaccinated at child s diagnosis. If siblings have a significant contact with chickenpox and are not immune, allow them to stay at home, but get them vaccinated if they don t develop the disease. Respiratory isolation for all identified cases. Zoster immunoglobulin (VZIG) All new oncology patients will have baseline serological testing for varicella immunity (preferably prior to any blood transfusions). Time: Should be given within 72 hours of contact. May be given up to 96 hours No indication for VZIG more than 96 hours after contact. Who: 1. All patients at risk who have had a significant shingles or chickenpox contact (as defined above) History of chickenpox, shingles, or Baseline Serology Action vaccine administration Negative Negative Give VZIG Positive Negative Give VZIG Negative Positive Give VZIG* Positive Positive No VZIG *Expert opinion is divided on this. Usually, VZIG is given regardless of serological results with a negative history. However, if the patient has not received a blood product that could have provided the passive antibody, some experts do not recommend VZIG administration. 2. All bone marrow transplant recipients at risk who have had a significant contact, regardless of their immune status at diagnosis Dosing Guidelines: Patient Weight Dose (maximum dose 625 units) Route 10 kg or less 125 units (1 vial) Intramuscular (IM) kg 250 units (2 vials) IM kg 375 units (3 vials) IM Guidelines for Varicella Zoster/Herpes Zoster January 2005 Page 4 of 6
5 Patient Weight Dose (maximum dose 625 units) Route kg 500 units (4 vials) IM More than 40 kg 625 units (5 vials) IM Effective for approximately 3-4 weeks. Repeat dose for further exposure more than 21 days after the last dose, if varicella did not develop. Isolate from other susceptible children, such as clinic patients, day 8 to day 28. Chickenpox may still occur as an attenuated illness. If this occurs, immediately contact a pediatric hematologist/oncologist. It must be treated with IV acyclovir. Acyclovir is only rarely indicated for chicken pox or shingles exposure and must be discussed with a pediatric hematologist/oncologist. If VZIG is unavailable, or for patients with a bleeding diathesis, IV gamma globulin 400 mg/kg over 3-4 hours attains an antibody titre approximately equivalent to VZIG. Varicella vaccination (Varivax, Varivax II, Varilrix ) Efficacy of the varicella vaccine is approximately 95% in normal hosts. This requires two doses in those over age 12 years, at least 28 days apart. Who: 1. All household contacts (see contraindications below) without a previous history of varicella disease or vaccination should receive the varicella vaccine at the time of an oncology diagnosis in a child. Consideration should be given to checking the titre of those who have a history of varicella disease or vaccination to confirm immunity. 2. Household contacts who are not immune to chickenpox (no previous disease or vaccination), and experience a chickenpox exposure, should receive the varicella vaccine immediately. Consider vaccination of siblings if child with cancer comes in contact with varicella and the sibling was not vaccinated at diagnosis or is not immune already. 3. Vaccination of children receiving maintenance treatment for acute lymphoblastic leukemia (who do not have documented immunity either by previous disease or vaccination), should be considered after one year of continuous remission when the child has a lymphocyte count >700/µL (0.7 x 10 9 /L) and a platelet count >100 x 10 9 /L. This must be discussed with the pediatric hematologist/oncologist. 4. All patients (except bone marrow transplant), without a previous history of varicella disease or vaccination, and titre is non-immune, should receive varicella vaccine 6 months after completing chemotherapy. 5. In consultation with pediatric hematology/oncology and immunology, all bone marrow transplant patients should receive the varicella vaccine 24 months after transplant. Consideration should be given to administering this vaccine based on a risk benefit assessment and level of immune suppression and assessment of immune competence and T cell number and function. Consideration may be given to administering the vaccine 18 months post transplantation in selected patients with documented adequate T cell number and function. Varicella vaccine should not be administered if evidence of GVHD or continued immunosuppression is present and until 3 months after stopping all chronic GVHD therapy, if >18 months post transplant. The varicella vaccine should be administered only after seroconversion to MMR and Hepatitis B is demonstrated. Guidelines for Varicella Zoster/Herpes Zoster January 2005 Page 5 of 6
6 6. Varicella vaccine may be given concurrently with MMR vaccine in a different site. If not given concurrently, a one month interval is needed between vaccines. Varicella vaccine can be given during the same visit with killed vaccines (e.g., DTaP, IPV, and HiB) in a different site. 7. Avoid pregnancy for 12 weeks and salicylates for 6 weeks after vaccination. Contraindications to vaccine: pregnancy age < one year old receiving chronic systemic steroids ( 2 mg/kg per day of prednisone or its equivalent, or 20 mg/day of prednisone or its equivalent if weight > 10 kg) immunodeficiency state sensitivity to vaccine components Dosage: Varivax II ml subcutaneously (subq) x 1 dose for ages 1-12 years Varivax II ml subcutaneously (subq) x 2 doses 4-8 weeks apart for ages 13 years or see package insert for the specific product currently available. Note: A local rash at the site (or the portion of the limb) of vaccination is expected in 4% of children and 8% of adults. If this occurs, the site should be kept covered. VZIG is not indicated if the oncology patient has not been directly exposed to the lesions. A disseminated rash (widespread or spread beyond the local area of the injection site) is rarer. If this occurs, the oncology patient should receive VZIG Treatment of Chickenpox/Shingles: All immunosuppressed patients should inform their physician immediately at first signs of chickenpox infection. Confirmation is often clinically obvious but in some cases direct viral smear or culture will be required. All children who develop chickenpox or shingles must be admitted to hospital for observation and intravenous acyclovir. Some lower risk patients may be considered for oral therapy to complete a course of IV acyclovir, but only after consultation with a pediatric hematologist/oncologist. They must continue to have frequent reassessment. Management: 1. Stop chemotherapy and consult with oncologist concerning any administration. 2. Start acyclovir immediately. For children 1 year of age, use acyclovir 1500 mg/m 2 /day IV in 3 divided doses for 7-10 days. For children < 1 year of age, use acyclovir 30 mg/kg/day IV in 3 divided doses for 7-10 days. If completing a course orally, use acyclovir 80 mg/kg/day in 4 divided doses (maximum 4000 mg/day) Guidelines for Varicella Zoster/Herpes Zoster January 2005 Page 6 of 6
7 3. Ensure adequate hydration at a minimum of 1500 ml/m²/day. 4. Monitor for systemic involvement - liver function tests, respiratory and neurological status. 5. Monitor renal function. 6. General management: Local control measures: cut finger nails short, keep nails clean, treat secondary infection, Calamine and/or Benadryl for itchiness, cool baths soothe and Aveeno baths may lessen itchiness. Avoid Aspirin or any product containing acetylsalicylic acid (risk of Reye s syndrome). Discourage breakage of blisters. Encourage oral intake with clear fluids. Monitor fever, appetite, fluid intake and appearance of lesions. Isolate child in hospital with airborne precautions. Notify infection control. 7. After discharge, instruct the family to contact the physician to be seen, or return immediately if child develops: secondary fever cough zoster (shingles) dissemination jaundice signs of bleeding into the lesions and the platelets are low (risk of hemorrhagic varicella is low but the child must return if occurs.) References: 1. Altman AJ, Wolff LT. The prevention of infections. In: Altman AJ, editor. Supportive care of children with cancer. 3 rd ed. Baltimore: John Hopkins University Press; 2004, p American Academy of Pediatrics. Varicella-zoster infections. In: Pickering LK, editor. Red Book 2003 Report of the Committee on Infectious Diseases. 26 th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2003, p American Academy of Pediatrics. Antiviral drugs for no-human immunodeficiency virus infections. In: Pickering LK, editor. Red Book 2003 Report of the Committee on Infectious Diseases. 26 th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2003, p Hastings C. Immunization. In: Altman AJ, editor. Supportive care of children with cancer. 3 rd ed. Baltimore: John Hopkins University Press; 2003, p IWK Health Centre. Children with cancer: A handbook for families. Halifax, Nova Scotia: IWK Health Centre; 2003, p IWK Health Centre. Formulary of Drugs and Dosing Manual, 7 th edition. Halifax, Nova Scotia: IWK Health Centre; 2004/ IWK Health Centre. Infection Control Manual. Transmission summary tables for acute care centers. Halifax, Nova Scotia: IWK Health Centre; 2004, p. 52. Date: 25 January 2005 Guidelines for Varicella Zoster/Herpes Zoster January 2005 Page 7 of 6
Viral Infections. 1. Prophylaxis management of patient exposed to Chickenpox:
This document covers: 1. Chickenpox post exposure prophylaxis 2. Chickenpox treatment in immunosuppressed/on treatment patients 3. Management of immunosuppressed exposed to Measles All children with suspected
More informationRecommendations for VZV management in. Dan Engelhard, Pierre Reusser, Rafael de la Camara, Hermann Einsele, Jan Styczynski, Kate Ward, Per Ljungman
Recommendations for VZV management in patients Cas cliniques with leukemia Dan Engelhard, Pierre Reusser, Rafael de la Camara, Hermann Einsele, Jan Styczynski, Kate Ward, Per Ljungman Introduction Acute
More informationTo provide guidance on prevention and control of illness caused by varicella-zoster virus (VZV).
Effective Date: 04/18 Replaces: 0 4 / 1 3 / 1 7 Page 1 of 4 POLICY: To provide guidance on prevention and control of illness caused by varicella-zoster virus (VZV). DEFINITIONS Two syndromes occur from
More informationTransplantation (Hematopoietic Stem Cell Transplantation (HSCT)) Immunization Recommendations
Atlantic Provinces Pediatric Hematology Oncology Network Réseau d oncologie et d hématologie pédiatrique des provinces de l Atlantique 5850/5980 University Avenue, PO Box 9700, Halifax, NS, B3K 6R8, 1.902.470.7429,
More informationLRI Children s Hospital. Management of chicken pox exposure in paediatrics
LRI Children s Hospital Management of chicken pox exposure in paediatrics Staff relevant to: Clinical staff working within the UHL Children s Hospital. Team approval date: October 018 Version: V 3 Revision
More informationIMMUNIZATION PROTOCOLS FOR PHARMACISTS. VARICELLA Live Virus Vaccine
IMMUNIZATION PROTOCOLS FOR PHARMACISTS VARICELLA Live Virus Vaccine I. ORDER: 1. Screen for contraindications and evidence of immunity (Section VII.K.) 2. Provide a current Vaccine Information Statement
More informationChickenpox Procedure. (IPC Policy Manual)
Chickenpox Procedure (IPC Policy Manual) DOCUMENT CONTROL: Version: 1 Ratified by: Clinical Policy Approval Group Date ratified: 3 July 2018 Name of originator/author: Senior Clinical Nurse Specialist
More informationSpots and Pox: Contact Tracing and Follow Up for Measles and Chickenpox
Spots and Pox: Contact Tracing and Follow Up for Measles and Chickenpox Noelle Bessette, MPH Surveillance Specialist New Jersey Department of Health Vaccine Preventable Disease Program Chickenpox Caused
More informationChickenpox Notification
Goolwa Campus: (08) 8555 7500 Victor Harbor Campus: (08) 8551 0900 Investigator College Chickenpox Notification Date for Distribution: 2018 Dear Parents/Caregivers There has been a case of chickenpox reported
More informationSpots and Pox: Contact Tracing and Follow Up for Measles and Chickenpox
Chickenpox Spots and Pox: Contact Tracing and Follow Up for Measles and Chickenpox Noelle Bessette, MPH Surveillance Specialist New Jersey Department of Health Vaccine Preventable Disease Program Caused
More informationAcyclovir dose for chicken pox
Buscar... Acyclovir dose for chicken pox Acyclovir (Zovirax) treats infections caused by the herpes viruses including genital herpes, cold sores, shingles and chicken pox. Includes Acyclovir side effects.
More informationProf Dr Najlaa Fawzi
1 Prof Dr Najlaa Fawzi is an acute highly infectious disease, characterized by vesicular rash, mild fever and mild constitutional symptoms. is a local manifestation of reactivation of latent varicella
More informationLECTURE OUTLINE. B. AGENT: Varicella-zoster virus. Human herpes virus 3. DNA virus.
Viral Vaccines II LECTURE OUTLINE 5/24/04 I. CASE HISTORY A 5-year old comes home from school with a red skin rash on his chest that spreads to over 300 itchy blisters that spread further to his face,
More informationGuidelines for immunisation of children following treatment with high dose chemotherapy and Haematopoietic Stem Cell Transplantation (HSCT)
Guidelines for immunisation of children following treatment with high dose chemotherapy and Haematopoietic Stem Cell Transplantation (HSCT) Version 2.0 Approved by Haem / Onc Senior Clinical Management
More informationSTANDARD OPERATING PROCEDURE (SOP) CHICKENPOX [VARICELLA ZOSTER VIRUS (VZV)]
Page 1 of 9 SOP Objective To ensure that patients with chickenpox (Varicella Zoster Virus) are cared for appropriately and actions are taken to minimise the risk of cross-infection. This SOP applies to
More informationVaccination to protect against shingles
Vaccination to protect against shingles - An update for registered healthcare practitioners The programme from September 2018 and contraindications and precautions Revised July 2018 NES and HPS accept
More informationHealth Care Worker (Pregnant) - Infectious Diseases Risks and Exposure
1. Purpose The purpose of this guideline is to provide accurate information on the risks to pregnant Health Care Workers (HCWs) in the event of an exposure to a transmissible infectious disease at the
More informationDisseminated shingles acyclovir
Disseminated shingles acyclovir The Borg System is 100 % Disseminated shingles acyclovir Two developed disseminated herpes zoster, one developed cytomegalovirus. Reduced response to acyclovir,. Disseminated
More informationVARICELLA. Infectious and Tropical Pediatric Division, Department of Child Health, Medical Faculty, University of Sumatera Utara
VARICELLA (Chicken pox) Infectious and Tropical Pediatric Division, Department of Child Health, Medical Faculty, University of Sumatera Utara Definition : Varicella is a common contagious disease caused
More informationSection 10.5 Varicella
Section 10.5 Varicella Chickenpox Introduction Transmission Signs and Symptoms Complications Diagnosis Treatment Infection Prevention and Control Precautions for Residents with Chickenpox Additional considerations
More informationShingles Procedure. (IPC Policy Manual)
Shingles Procedure (IPC Policy Manual) DOCUMENT CONTROL: Version: 1.1 Ratified by: Clinical Policy Approval Group Date ratified: 3 July 2018 Name of originator/author: Senior Clinical Nurse Specialist
More informationChickenpox Death. West Virginia Electronic Disease Surveillance System
Chickenpox Death Electronic Disease Surveillance System Division of Surveillance and Disease Control Infectious Disease Epidemiology Program Phone: 304-558-5358 or 800-423-1271 in Fax: 304-558-8736 Investigation
More informationSouthern Derbyshire Shared Care Pathology Guidelines. Varicella Zoster Virus (VZV)
Southern Derbyshire Shared Care Pathology Guidelines Varicella Zoster Virus (VZV) Purpose of guideline This guideline provides information about the definition of significant exposure to VZV and management
More informationThe Northern Kentucky Health Department advises that you take the following actions:
February 5, 2019 Dear Parent or Guardian, This letter is to inform you that your child s school, Assumption Academy, is currently experiencing an outbreak of an illness that is accompanied by a blister-like
More informationApproximately 25% of people develop shingles during their lifetime, with the majority of cases occurring in those over 50 years of age.
ÜNZÜLE ALPASLAN WHAT IS SHINGLES? Shingles is an infection of an individual nerve and the skin surface that is supplied by the nerve; it is caused by the varicella-zoster virus - the same virus that causes
More informationSeasonal Influenza. Provider Information Sheet. Infectious Disease Epidemiology Program
August 2007 te: This sheet contains information on seasonal influenza. For information on avian or pandemic influenza, contact the (800-423-1271 or 304-558-5358). What is influenza-like illness (ILI)?
More informationGuidelines for the immunisation of children following treatment with Standard-Dose Chemotherapy
Guidelines for the immunisation of children following treatment with Standard-Dose Chemotherapy Version 2.0 Approved by Haem / Onc Senior Clinical Management team Date Approved March 2015 Ratified by:
More informationIMMUNISATION OF CHILDREN DURING and AFTER CANCER THERAPY
NATIONAL GUIDELINES PAEDIATRIC ONCOLOGY AND HAEMATOLOGY For the Care of Childhood Cancer in Specialist Child Cancer and Shared Care Centres. IMMUNISATION OF CHILDREN DURING and AFTER CANCER THERAPY Date
More informationImmunizing the Immunocompromised. Leilani T. Sanchez, MD, DPPS, DPIDSP Crowne Plaza Galleria Manila, 21 February 2013
Immunizing the Immunocompromised Leilani T. Sanchez, MD, DPPS, DPIDSP Crowne Plaza Galleria Manila, 21 February 2013 WHO World Health Statistics 2012 2 Immunizing the Immunocompromised Leilani T. Sanchez
More informationICM VI-09 DEFINITION REFERENCES
TITLE/DESCRIPTION: MANAGEMENT OF SELECTED AIRBORNE AND DROPLET INFECTIOUS DISEASE EXPOSURES IN HEALTHCARE WORKERS INDEX NUMBER: EFFECTIVE DATE: APPLIES TO: ISSUING AUTHORITY: 01/01/2009 01/01/2013 All
More informationVaricella (Chickenpox) and Varicella Vaccines
Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Varicella (Chickenpox) and Varicella Vaccines September 2018 Photographs and images included in this
More informationImmunization for Adult Hematopoietic Stem Cell Transplant (HSCT) Recipients
Immunization for Adult Recipients January 4, 201 Immunization for Adult Hematopoietic Stem Cell Transplant () Recipients Revision Date: January 4, 201 Note: This guide is meant to supplement existing recommendations
More informationCLINICAL GUIDELINES. Summary of Literature and Recommendations Concerning Immunization and Steroid Injections Thomas J. Gilbert M.D., M.P.P.
CLINICAL GUIDELINES Summary of Literature and Recommendations Concerning Immunization and Steroid Injections Thomas J. Gilbert M.D., M.P.P. 11/2/15 Several practices routinely delay steroid injections
More informationEXANTHEMATOUS ILLNESS. IAP UG Teaching slides
EXANTHEMATOUS ILLNESS 1 DEFINITIONS Exanthema eruption of the skin Exanthema eruption of mucosae Macule flat nonpalpable lesion Papule small palpable lesion Nodule large palpable lesion Vesicle small fluid
More informationBy: Zenessa Morrison and Denise Bailey
By: Zenessa Morrison and Denise Bailey Shingles which is also known as Herpes Zoster is a painful skin rash caused by the Varicella virus. The Varicella virus belongs to the herpesviridae family. The structure
More informationVARICELLA. Dr Louise Cooley Royal Hobart Hospital
VARICELLA Dr Louise Cooley Royal Hobart Hospital Varicella Zoster Virus (VZV): The Basics Herpes virus Exclusively human infection Primary infection: varicella (chickenpox) Neurotropic, establishing latency
More informationMeasles 2015: What We Need to Know
Faculty Measles 2015: What We Need to Know Karen Landers, MD, FAAP Assistant State Health Officer Tuberculosis Control and Immunization Alabama Department of Public Health Produced by the Alabama Department
More informationPatient Group Direction for Varicella vaccine Version: Varicella Start Date: 1 st May 2014 Expiry Date: 30 th April 2017
Patient Group Direction for Varicella vaccine Version: Varicella 2014.1 Start Date: 1 st May 2014 Expiry Date: 30 th April 2017 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS:
More informationImmunization for Child Hematopoietic Stem Cell Transplant (HSCT) Recipients
Immunization for Child Recipients January 4, 201 Immunization for Child Hematopoietic Stem Cell Transplant () Recipients Revision Date: January 4, 201 Note: This guide is meant to supplement existing recommendations
More informationOREGON HEALTH AUTHORITY IMMUNIZATION PROTOCOL FOR PHARMACISTS LIVE ZOSTER VACCINE
OREGON HEALTH AUTHORITY IMMUNIZATION PROTOCOL FOR PHARMACISTS LIVE ZOSTER VACCINE Revisions as of /4/10 Zostavax should not be given concomitantly with Pneumovax 3 due to reduced immune response to Zostavax.
More informationVARICELLA ZOSTER (CHICKENPOX/SHINGLES) INFECTION CONTROL PROCEDURE
Reference Number: UHB 076 Version Number: 2 Date of Next Review: 23 June 2018 Previous Trust/LHB Reference Number: IPCD Policy No 8 T/45 VARICELLA ZOSTER (CHICKENPOX/SHINGLES) INFECTION CONTROL PROCEDURE
More informationA summary of guidance related to viral rash in pregnancy
A summary of guidance related to viral rash in pregnancy Wednesday 12 th July 2017 Dr Rukhsana Hussain Introduction Viral exanthema can cause rash in pregnant women and should be considered even in countries
More informationVaccination against shingles for adults aged 70 and 79 years of age Q&A s for healthcare professionals
Vaccination against shingles for adults aged 70 and 79 years of age Q&A s for healthcare professionals Background In 2010, the Joint Committee on Vaccination and Immunisation (JCVI) 1 were asked by the
More informationPertussis. Information for Physicians. Disease Information. Diagnostic Testing of Suspect Cases. Infectious Disease Epidemiology Program
September 2007 Pertussis Disease Information Incubation Period: 7-10 days; rarely up to 21 days Infectious Period: From prodrome (early symptom) onset to 3 weeks after cough onset. Patients are considered
More informationWrite an account on laboratory diagnosis and prevention of chickenpox virus?
Write an account on laboratory diagnosis and prevention of chickenpox virus? The clinical presentations of varicella or zoster are so characteristic that laboratory confirmation is rarely required. Laboratory
More informationIt is crucial that practitioners refer to this updated chapter when administering the shingles vaccine.
In October Public Health England published a revised Green Book chapter for shingles and also health care professional FAQs. These revisions include changes to the contraindications and precautions sections.
More informationPatient Group Direction for Varicella vaccine Version: Varicella Start Date: 1 st April 2016 Expiry Date: 31 st March 2019
Patient Group Direction for Varicella vaccine Version: Varicella 2016.1 Start Date: 1 st April 2016 Expiry Date: 31 st March 2019 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS:
More informationAlphaherpesvirinae. Simplexvirus (HHV1&2/ HSV1&2) Varicellovirus (HHV3/VZV)
Alphaherpesvirinae Simplexvirus (HHV1&2/ HSV1&2) Varicellovirus (HHV3/VZV) HERPES SIMPLEX VIRUS First human herpesvirus discovered (1922) Two serotypes recognised HSV-1 & HSV-2 (1962) HSV polymorphism
More informationVaccination to protect against shingles - An update for registered healthcare practitioners
Vaccination to protect against shingles - An update for registered healthcare practitioners The programme from September 2016 and contraindications and precautions September 2016 NES and HPS accept no
More informationH1N1-A (Swine flu) and Seasonal Influenza
H1N1-A (Swine flu) and Seasonal Influenza Influenza, commonly known as the flu, is a contagious viral disease that typically occurs in the winter months and causes cough, fever, sore throat, headache,
More informationVARICELLA/ZOSTER (CHICKENPOX/SHINGLES) SURVEILLANCE PROTOCOL FOR ONTARIO HOSPITALS
VARICELLA/ZOSTER (CHICKENPOX/SHINGLES) SURVEILLANCE PROTOCOL FOR ONTARIO HOSPITALS Developed by the Ontario Hospital Association and the Ontario Medical Association Joint Communicable Diseases Surveillance
More informationMEASLES HEALTH ALERT/ADVISORY. Date: February 5, Dear Colleague:
MEASLES HEALTH ALERT/ADVISORY Date: February 5, 2019 Dear Colleague: Details of situation: Five measles cases, four between the ages of 12 to 21 months, have been reported in three different counties within
More informationIMMUNIZATION IN CHILDREN WITH CANCER
SIOP PODC Supportive Care Education Presentation Date: 05 th September 2014 Recording Link at www.cure4kids.org: http://www.cure4kids.org/ums/home/conference_rooms/enter.php?room=p2xokm5imdj Email: ahmed.naqvi@sickkids.ca
More informationInfection Prevention and Control (IPC)
Infection Prevention and Control (IPC) Standard Operating Procedure for CHICKENPOX (VARICELLA ZOSTER VIRUS) in a healthcare setting WARNING This document is uncontrolled when printed. Check local intranet
More informationOCCUPATIONAL HEALTH DISEASE SPECIFIC RECOMMENDATIONS
Herpes simplex virus (HSV) Cold sores Genital herpes Herpetic whitlow OCCUPATIONAL HEALTH DISEASE SPECIFIC RECOMMENDATIONS contact with primary or recurrent lesions, infectious saliva or genital secretions
More informationMEASLES. Tracey Johnson Infection Control Specialist Nurse
MEASLES Tracey Johnson Infection Control Specialist Nurse Overview Measles is a highly infectious viral illness. Measles virus is contained in the millions of tiny droplets produced when an infected person
More informationVaricella and varicella vaccination An update
THEME: School contagions Varicella and varicella vaccination An update John Litt, Margaret Burgess BACKGROUND Although varicella is generally mild in children, it is often more severe in adults and overall
More informationSubunit adjuvanted zoster vaccine: why the fuss?
Subunit adjuvanted zoster vaccine: why the fuss? Soren Gantt, MD PhD MPH Pediatric Infectious Diseases Vaccine Evaluation Center BC Children s Hospital University of British Columbia Disclosures Research
More informationBackground Rationale for resource
Background The Joint Committee on Vaccination and Immunisation 1 reviewed all the available medical, epidemiological and economic evidence as well as vaccine safety and efficacy relevant to offering a
More informationAdult immunisation update training. August 2017
Adult immunisation update training August 2017 What we will cover Whooping cough vaccine in pregnant women Shingles vaccine update MMR for adults Hepatitis A and B shortages Pertussis vaccine in pregnancy
More informationINTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION a Society that includes Basic Science, the Failing Heart, and Advanced Lung Disease
International Society of Heart and Lung Transplantation Advisory Statement on the Implications of Pandemic Influenza for Thoracic Organ Transplantation This advisory statement has been produced by the
More informationViruses. Poxviridae. DNA viruses: 6 families. Herpesviridae Adenoviridae. Hepadnaviridae Papovaviridae Parvoviridae
Viruses DNA viruses: 6 families Poxviridae Herpesviridae Adenoviridae Hepadnaviridae Papovaviridae Parvoviridae Human herpesviruses Three subfamilies (genome structure, tissue tropism, cytopathologic effect,
More informationShingles: What s New to Know
This material was prepared by the New England Quality Innovation Network-Quality Improvement Organization (NE QIN-QIO), the Medicare Quality Improvement Organization for New England, under contract with
More informationImmunization of Specific Populations (Immunosuppressed and Chronic Health Conditions)
Immunization of Specific Populations (Immunosuppressed and Chronic Health Conditions) Revision Date: January 4, 2018 Health Conditions Requiring Special Considerations for Immunization General Principles...
More informationChildhood Contagious Diseases)5(
Childhood Contagious Diseases)5( Children have maturing immune systems and are often in close proximity to one another, such as in day-care centers, classrooms, and on school buss. This makes the transmission
More informationHealthy Kansans living in safe and sustainable environments.
Healthy Kansans living in safe and sustainable environments. Vaccine-Preventable Disease (VPD) Investigations in Kansas Chelsea Raybern, Advanced Epidemiologist Mychal Davis, Epidemiologist Amie Worthington,
More informationObjectives. Immunity. Childhood Immunization Risk of Non-Vaccinated Children 12/22/2015
Childhood Immunization Risk of Non-Vaccinated Children Bertha P. Rojas, Pharm.D. PGY-1 Pharmacy Resident South Miami Hospital Objectives Understand the definition of herd immunity Identify vaccine-preventable
More informationHEALTH ADVISORY: MEASLES EXPOSURES IN NEW YORK STATE
December 11, 2018 To: Health Care Providers, Hospitals, Emergency Departments, Dental Providers, and Local Health Departments From: New York State Department of Health, Bureau of Immunization HEALTH ADVISORY:
More informationMeasles Update. March 16, 2015 Lisa Miller, MD, MSPH Communicable Disease Branch Chief Lynn Trefren MSN, RN Immunization Branch Chief
Measles Update March 16, 2015 Lisa Miller, MD, MSPH Communicable Disease Branch Chief Lynn Trefren MSN, RN Immunization Branch Chief Colorado Department of Public Health and Environment Presenters have
More informationSplenectomy Vaccine Protocol PIDPIC
Splenectomy Vaccine Protocol PIDPIC 6.24.14 Rationale Spleen clears encapsulated bacteria and infected erythrocytes Serves as one of the largest lymphoid tissues where B cells are educated against encapsulated
More informationImmunizations: guidelines & practice for live vaccines. Thor Wagner, M.D. Pediatric Infectious Diseases
Immunizations: guidelines & practice for live vaccines Thor Wagner, M.D. Pediatric Infectious Diseases Why immunizations are important for pediatric liver transplant recipients? National Vaccination Rates
More informationNegri Body and EM of Rabies Virus
Rhabdovirus Nearly 100% fatal after symptoms appear Bullet shaped virion Helical nucleocapsid Zoonotic Glycoprotein Binds to Nicotinic Ach receptors in the post-synaptic junction. Replicates in motor neurons
More informationPediatric Oncology: Vaccination After Therapy Family Practice Oncology CME Day November 2017
Pediatric Oncology: Vaccination After Therapy Family Practice Oncology CME Day November 2017 S. Rod Rassekh Pediatric Oncologist BC Children s Hospital Objectives Discuss the immune system and vaccination
More informationGeneral Recommendations. General Best Practice Guidelines 9/10/2018. General Best Practice Guidelines for Immunization Part 1
Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases General Best Practice Guidelines for Immunization Part 1 Chapter 2 September 2018 Photographs and images
More informationProducts available Methotrexate tablets 2.5mg ONLY (Methotrexate tablets 10mg are NOT recommended as per NPSA guidance 5 ).
Methotrexate Traffic light classification- Amber 1 Information sheet for Primary Care Prescribers Part of the Shared Care Protocol: Management of Rheumatological Conditions with Disease-Modifying Anti
More informationRoutine Immunization Products
Newfoundland and Labrador Immunization Manual Section 3 Routine Immunization Products Immunization with Diphtheria, Pertussis, Tetanus, Polio and Hib Vaccine (DTap-IPV- Hib 3.1 Immunization with Diphtheria,
More informationHuman Herpes Viruses (HHV) Mazin Barry, MD, FRCPC, FACP, DTM&H Assistant Professor and Consultant Infectious Diseases KSU
Human Herpes Viruses (HHV) Mazin Barry, MD, FRCPC, FACP, DTM&H Assistant Professor and Consultant Infectious Diseases KSU HERPES VIRUS INFECTIONS objectives: ØTo know the clinically important HHVs. ØTo
More informationNHS Greater Glasgow & Clyde SOP No. BMT Haemopoietic Stem Cell Transplantation Services Vaccination Policy
This policy was written with advice from Dr S Ahmed, Consultant in Public Health, Greater Glasgow & Clyde. We would like to thank him for his guidance. 1. Background It is recommended by EBMT and CDC that
More informationWOMENCARE. Herpes. Source: PDR.net Page 1 of 8. A Healthy Woman is a Powerful Woman (407)
WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 Herpes Basics: Herpes is a common viral disease characterized by painful blisters of the mouth or genitals. The herpes simplex virus (HSV) causes
More informationCommon Childhood Infections. BSME school nurses June Dr David Cremonesini
Common Childhood Infections BSME school nurses June 3 2016 Dr David Cremonesini Chicken Pox Contagious from 1-2 days BEFORE rash starts until all blisters crusted over (usually 5-6 days after rash) Commonly
More informationVARICELLA IN IMMUNOCOMPROMISED CHILDREN AT THE PHILIPPINE GENERAL HOSPITAL : A SIX-YEAR REVIEW
2 VARICELLA IN IMMUNOCOMPROMISED CHILDREN AT THE PHILIPPINE GENERAL HOSPITAL : A SIX-YEAR REVIEW AUTHORS: Elizabeth T. Escaño-Gallardo, M.D*, Lulu C. Bravo, M.D.* *Philippine General Hospital CORRESPONDENCE:
More informationModule 7: Case Discussion and Administration Technique
: Case Discussion and Administration Technique Miranda Wilhelm, Pharm.D. Clinical Associate Professor Department of Pharmacy Practice Southern Illinois University Edwardsville, School of Pharmacy 1 Disclosure
More informationHelp protect your child. At-a-glance guide to childhood vaccines.
Help protect your child. At-a-glance guide to childhood vaccines. 40976_CDCupdate.indd 1 Why vaccines matter. Thanks to widespread vaccination programs, several diseases that can infect our children have
More informationINFECTIOUS DISEASES POLICY
Purpose The purpose of this policy is to ensure that the control of infectious diseases and contagious conditions are effectively addressed through both preventative and management strategies. Scope This
More informationShingles prophylaxis acyclovir
Shingles prophylaxis acyclovir Search 27-2-2018 Detailed Acyclovir dosage information for adults and TEENren. Includes dosages for Herpes Simplex - Suppression, Herpes Simplex Labialis, Herpes Zoster.
More informationClinical Aspect and Application of Laboratory Test in Herpes Virus Infection. Masoud Mardani M.D,FIDSA
Clinical Aspect and Application of Laboratory Test in Herpes Virus Infection Masoud Mardani M.D,FIDSA Shahidhid Bh BeheshtiMdi Medical lui Universityit Cytomegalovirus (CMV), Epstein Barr Virus(EBV), Herpes
More informationPUBLIC HEALTH SIGNIFICANCE SEASONAL INFLUENZA AVIAN INFLUENZA SWINE INFLUENZA
INFLUENZA DEFINITION Influenza is an acute highly infectious viral disease characterized by fever, general and respiratory tract catarrhal manifestations. Influenza has 3 Types Seasonal Influenza Avian
More informationGuidance on Infection Control for Chickenpox and Shingles in Prisons, Immigration Removal Centres and other Prescribed Places of Detention
Guidance on Infection Control for Chickenpox and Shingles in Prisons, Immigration Removal Centres and other Prescribed October 2014 (third edition) About Public Health England Public Health England exists
More informationBackground Rationale for resource
Slide 1 Background The Joint Committee on Vaccination and Immunisation 1 reviewed all the available medical, epidemiological and economic evidence as well as vaccine safety and efficacy relevant to offering
More informationWessex Paediatric Oncology Guidelines: Management of viral infections, viral prophylaxis and vaccination guidance
Wessex Paediatric Oncology Guidelines: Management of viral infections, viral prophylaxis and vaccination guidance Scope This guideline applies to all Paediatric Oncology patients in the region. It does
More informationManagement of Varicella Zoster Virus Infections
Management of Varicella Zoster Virus Infections Federal Bureau of Prisons Clinical Practice Guideline January 2009 What s New in this Document? Overview of available varicella laboratory tests (Appendix
More informationHIGH RISK IMMUNISATION
Overview HIGH RISK IMMUNISATION Dr. F Shaun Hosein Advanced Trainee, Public Health Medicine Sunshine Coast Public Health Unit Lecturer, University of Queensland Clinical Writer PHN Immunology Responses
More informationCommunicable Disease Control Varicella Zoster June 2018 Page 1 TABLE OF CONTENTS
Page 1 TABLE OF CONTENTS 1.0 AUTHORITY... 2 2.0 GOAL... 2 2.1 Targets for Immunization Coverage and Hospitalization in Children... 2 3.0 EPIDEMIOLOGIC FEATURES OF VARICELLA ZOSTER INFECTION... 2 4.0 CASE
More informationSMALLPOX QUESTIONS AND ANSWERS: The Disease and the Vaccine
SMALLPOX QUESTIONS AND ANSWERS: The Disease and the Vaccine In General What should I know about smallpox? Smallpox is an acute, contagious, and sometimes fatal disease caused by the variola virus (an orthopoxvirus),
More informationAcyclovir for ear infections
Acyclovir for ear infections The Borg System is 100 % Acyclovir for ear infections User feedback about Acyclovir side effects covering chicken pox, fatigue, shingles, hair loss, HSV2, dosage, anemia, ear
More informationChapters 21-26: Selected Viral Pathogens
Chapters 21-26: Selected Viral Pathogens 1. DNA Viral Pathogens 2. RNA Viral Pathogens 1. DNA Viral Pathogens Smallpox (pp. 623-4) Caused by variola virus (dsdna, enveloped): portal of entry is the respiratory
More informationANTIBIOTIC GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED MENINGITIS AND ENCEPHALITIS IN ADULTS
ANTIBIOTIC GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED MENINGITIS AND ENCEPHALITIS IN ADULTS Version 4.0 Date ratified February 2009 Review date February 2011 Ratified by Authors Consultation Evidence
More informationChancroid Table of Contents
Subsection: Chancroid Page 1 of 8 Chancroid Table of Contents Chancroid Fact Sheet Subsection: Chancroid Page 2 of 8 Chancroid (Haemophilus ducreyi) Overview (1,2) For a more complete description of chancroid,
More information